These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2076654)

  • 21. Comparison of miconazole- and ketoconazole-induced release of K+ from Candida species.
    Beggs WH
    J Antimicrob Chemother; 1983 Apr; 11(4):381-3. PubMed ID: 6304001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of imidazole antifungals on the development of germ tubes by strains of Candida albicans.
    Johnson EM; Richardson MD; Warnock DW
    J Antimicrob Chemother; 1983 Oct; 12(4):303-16. PubMed ID: 6315670
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Anti-Candida activities of azole antifungals in the presence of lysozyme in vitro].
    Abe S; Tansho S; Perera PD; Hiratani T; Nishiyama Y; Uchida K; Yamaguchi H
    Nihon Ishinkin Gakkai Zasshi; 1998; 39(2):103-7. PubMed ID: 9580036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential of bifonazole for direct lethal action.
    Beggs WH
    Drugs Exp Clin Res; 1990; 16(11):543-7. PubMed ID: 2101777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The action of imidazole against bacteria.
    Retico A; Apuzzo G; Simonetti N
    J Chemother; 1989 Jul; 1(4 Suppl):235-7. PubMed ID: 16312383
    [No Abstract]   [Full Text] [Related]  

  • 26. [The comparison of susceptibility of Candida albicans and Candida glabrata to miconazole].
    Kurnatowski P; Makieło L; Horwatt-Bozyczko E
    Wiad Parazytol; 2001; 47(4):867-73. PubMed ID: 16886440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro anti-Candida activity of certain new 3-(1H-imidazol-1-yl)propan-1-one oxime esters.
    Attia MI; Zakaria AS; Almutairi MS; Ghoneim SW
    Molecules; 2013 Sep; 18(10):12208-21. PubMed ID: 24084023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activities of miconazole, miconazole nitrate, and ketoconazole alone and combined with rifampin against Candida spp. and Torulopsis glabrata recovered from cancer patients.
    Moody MR; Young VM; Morris MJ; Schimpff SC
    Antimicrob Agents Chemother; 1980 May; 17(5):871-5. PubMed ID: 6249197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antifungal agents. III. Naphthyl and thienyl derivatives of 1H-imidazol-1-yl-4-phenyl-1H-pyrrol-3-ylmethane.
    Massa S; Di Santo R; Costi R; Simonetti G; Retico A; Apuzzo G; Artico M
    Farmaco; 1993 Jun; 48(6):725-36. PubMed ID: 8373500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Azole resistance in Candida albicans.
    Smith KJ; Warnock DW; Kennedy CT; Johnson EM; Hopwood V; Van Cutsem J; Vanden Bossche H
    J Med Vet Mycol; 1986 Apr; 24(2):133-44. PubMed ID: 3014106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 1-[(3-Aryloxy-3-aryl)propyl]-1H-imidazoles, new imidazoles with potent activity against Candida albicans and dermatophytes. Synthesis, structure-activity relationship, and molecular modeling studies.
    La Regina G; D'Auria FD; Tafi A; Piscitelli F; Olla S; Caporuscio F; Nencioni L; Cirilli R; La Torre F; De Melo NR; Kelly SL; Lamb DC; Artico M; Botta M; Palamara AT; Silvestri R
    J Med Chem; 2008 Jul; 51(13):3841-55. PubMed ID: 18529046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro susceptibility studies with oxiconazole (Ro 13-8996).
    Gebhart RJ; Espinel-Ingroff A; Shadomy S
    Chemotherapy; 1984; 30(4):244-7. PubMed ID: 6086246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An evaluation of the antifungal effect of bifonazole on Torulopsis glabrata and Candida albicans under various in vitro test conditions.
    Barug D; Bastiaanse HB
    Arzneimittelforschung; 1983; 33(4):524-8. PubMed ID: 6409128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of in-vitro activity of miconazole and ketoconazole in phospholipid formulations.
    De Logu A; Fadda AM; Anchisi C; Maccioni AM; Sinico C; Schivo ML; Alhaique F
    J Antimicrob Chemother; 1997 Dec; 40(6):889-93. PubMed ID: 9462444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct membrane-damaging effect of sertaconazole on Candida albicans as a mechanism of its fungicidal activity.
    Agut J; Palacín C; Salgado J; Casas E; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1992 May; 42(5A):721-4. PubMed ID: 1627191
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis of (E)-1-(5-chlorothien-2-yl)-2-(1H-imidazol-1-yl)ethanone 2,6-dichlorophenylhydrazone hydrochloride, a novel, orally active antifungal agent.
    Dyer RL; Ellames GJ; Hamill BJ; Manley PW; Pope AM
    J Med Chem; 1983 Mar; 26(3):442-5. PubMed ID: 6298430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of imidazole- and triazole-derivative antifungal compounds on the growth and morphological development of Candida albicans hyphae.
    Odds FC; Cockayne A; Hayward J; Abbott AB
    J Gen Microbiol; 1985 Oct; 131(10):2581-9. PubMed ID: 2999296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and antimycotic activity of alpha-aryl-beta,N-imidazolylalkyl benzyl ethers.
    Tajana A; Cappelletti R; Leonardi A; Nardi D; Veronese M
    Arzneimittelforschung; 1981; 31(12):2121-3. PubMed ID: 6800383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antifungal agents. 11. N-substituted derivatives of 1-[(aryl)(4-aryl-1H-pyrrol-3-yl)methyl]-1H-imidazole: synthesis, anti-Candida activity, and QSAR studies.
    Di Santo R; Tafi A; Costi R; Botta M; Artico M; Corelli F; Forte M; Caporuscio F; Angiolella L; Palamara AT
    J Med Chem; 2005 Aug; 48(16):5140-53. PubMed ID: 16078834
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of ergosterol synthesis by sertaconazole in Candida albicans.
    Agut J; Palacín C; Sacristán A; Ortiz JA
    Arzneimittelforschung; 1992 May; 42(5A):718-20. PubMed ID: 1627190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.